Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Wednesday, June 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. announced that John Wiggins, Vice President of External Manufacturing, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference. The event is scheduled for 8:40 a.m. ET on June 9. The conference participation underscores Lantheus's commitment to improving patient outcomes through their innovative radiopharmaceutical solutions, which the company has provided for 70 years.
Price reaction · baseline $96.3 (2026-06-02 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close · peak
+4.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is actively participating in a major healthcare conference.
  • The company's focus is on improving patient outcomes through radiopharmaceuticals.
  • The presence of a Vice President at the event highlights the company's commitment to investor engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced John Wiggins, Vice President, External Manufacturing, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference at 8:40 a.m. ET on Tuesday, June 9.
To access the live webcast of the presentations, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentation.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.

Frequently Asked Questions

When will John Wiggins speak at the Goldman Sachs Conference?

John Wiggins will participate in the fireside chat on June 9 at 8:40 a.m. ET.

How can I access the live webcast of the presentations?

The live webcast can be accessed on Lantheus' Investors section at their website.

How long will the webcast replay be available?

A replay of the webcasts will be available for at least 30 days after the live event.

What does Lantheus focus on as a company?

Lantheus specializes in radiopharmaceuticals to help clinicians Find, Fight, and Follow disease.

Where is Lantheus headquartered?

Lantheus is headquartered in Massachusetts and has offices in various countries.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Lantheus Goldman Sachs healthcare conference radiopharmaceutical patient outcomes
Last updated: Jun 3, 2026

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →